Largecaps stable; mid/smallcaps may correct more.
Earnings downgrades are likely, but much of it is already priced in; focus shifts to FY27 outlook.
Stock-picking is key; financials and pharma favored over overvalued export and industrial themes.
IT sector outlook is stable; AI may expand opportunities more than it threatens margins.
Comments
Post a Comment